NEW YORK CITY, NY / ACCESS Newswire / July 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nutex Health, Inc. ("Nutex" or "the Company") (NASDAQ:NUTX). Investors who purchased Nutex securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NUTX.
Investigation Details
On July 22, 2025, Blue Orca Capital published a report alleging, among other things, that Nutex’s share price has "surged" after it "began submitting the majority of its patient bills to the arbitration process for settling out-of-network medical bills . . . using an unidentified ‘third party IDR vendor.’" The report further states that the "mystery consultant" is HaloHD, which, according to multiple lawsuits, has "engag[ed] in a coordinated fraudulent scheme to steal millions of dollars from insurance companies on behalf of and in conjunction with its healthcare billing clients." Following this news, Nutex stock price dropped.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Nutex securities, you can assist this investigation by visiting the firm’s site: bgandg.com/NUTX. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
COMTEX_467628353/2457/2025-07-28T13:17:04